Friday, July 24, 2015

U.S. Approves Drug That Can Sharply Lower Cholesterol Levels by ANDREW POLLACK


By ANDREW POLLACK

The drugs, Praluent, developed by Sanofi and Regeneron, is expected to become the next flashpoint in the growing controversy of escalating pharmaceutical price.

Published: July 25, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1fspKB1



from WordPress http://ift.tt/1DCBYwx
via Hadi Aboukhater

No comments:

Post a Comment